> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fresenius Recall Triggers QuVa Pharma Recall
- URL: https://www.fdaweb.com/fresenius-recall-triggers-quva-pharma-recall/
- Published: 2020-04-29T12:00:00.000Z
- Updated: 2026-09-14T16:13:06.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5146682

FDA says QuVa Pharma is recalling all lots of RECK (ropivacaine, epinephrine, clonidine, ketorolac) 50 ml in sodium chloride-60 ml BD syringe that were prepared using sterile ketorolac being recalled by Fresenius Kabi. An FDA recall [notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabis-recall-ketorolac-results-quva-pharmar-recall-compounded-sterile-product-reck?ref=fdaweb.com#recall-announcement) says Fresenius recalled multiple lots of ketorolac 4/20 due to the presence of particulate matter found in the reserve sample vials.